Form4insider filings, from the source

SEC Form 4 · accession 0001012975-17-000639

Syros Pharmaceuticals, Inc. · SYRS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Noubar Afeyan
10% Owner
Period of report
Aug 17, 2017
Accepted (ET)
Aug 21, 2017 · 4:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001556263

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Aug 17, 2017J1,295,997—D2,378,663D
Common StockF1,F3Aug 17, 2017J306,222—D612,442ISee Footnote
Common StockF1,F4Aug 17, 2017J54,293—D0ISee Footnote
Common StockF5holding———213,332ISee Footnote
Common StockF1,F6holding———24,527ISee Footnote
Common StockF1,F7holding———24,527ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses